Brayton Purcell LLP

Call For A Free Consultation
800-598-0314

Call For A Free Consultation 800-598-0314

Brayton Purcell LLP
  • Home
  • Firm Overview
    • Our Beliefs
      • Giving Back
      • Our Associations And Memberships
      • The Right To Trial By Jury
    • Regions Served
    • Careers
    • Our Employees Pets
    • Press Releases
  • Attorneys
  • Practice Areas
    • Mesothelioma/Asbestos
    • Personal Injury/Wrongful Death
    • Toxic Substances
    • Estate Planning
    • Other Areas Of Practice
  • Court Successes
    • Trial Verdicts
    • Appeals
  • Testimonials
  • Blog
  • Videos
  • Contact
  • Home
  • Firm Overview
    • Our Beliefs
      • Giving Back
      • Our Associations And Memberships
      • The Right To Trial By Jury
    • Regions Served
    • Careers
    • Our Employees Pets
    • Press Releases
  • Attorneys
  • Practice Areas
    • Mesothelioma/Asbestos
    • Personal Injury/Wrongful Death
    • Toxic Substances
    • Estate Planning
    • Other Areas Of Practice
  • Court Successes
    • Trial Verdicts
    • Appeals
  • Testimonials
  • Blog
  • Videos
  • Contact

Study: modified T cells successful against mesothelioma tumors

by Brayton Purcell LLP | Nov 18, 2014 | Mesothelioma

Asbestos is a significant public health hazard for at least two reasons. First, it is everywhere. During the last century, it was employed in thousands of uses, in millions of locations, ranging from kitchen potholders to insulation on industrial steam boilers. Thousands of workers across decades who directly worked with installing and servicing equipment using asbestos products have developed asbestosis and mesothelioma.

The other element that makes it so significant is that once mesothelioma develops, it is almost always incurable, leading to a painful death for the victim. And with asbestos located in millions of locations throughout the U.S., every day more people are unwittingly exposed to the deadly fibers.

So, word of any medical advancements in the fight against mesothelioma are always welcome news. A recent study was published which showed the potential of genetically-modified T cells being used to target and kill mesothelioma tumors.

Researchers were encouraged with their strategy, as the altered white blood cells not only recognized the tumors and were able to successfully attack and eliminate them after the injection, but they appeared to cause other T cells to “activate” and created a persistent resistance to cancer.

When researchers reintroduced a cancer tumor 200 days after the first injection of the T cells, the remaining T cells successfully eliminated that tumor.

It is hoped that this success will lead to approval by the Food and Drug Administration for a safety trial next year. It would be remarkable news if this research leads to the eventual development of an effective treatment to stop mesothelioma, and of great service to the thousands who develop mesothelioma every year.

Latimes.com, “Genetically modified cells learn to fight mesothelioma,” Geoffrey Mohan, November 5, 2014

Recent Posts

  • U.S. asbestos imports jump in 2020
  • The dangers of homes built with asbestos
  • Four jobs at risk of asbestos exposure
  • 5 Common Products You Might be Shocked to Learn Contain Asbestos
  • You never know where you will find asbestos on your property

Archives

Categories

RSS Feed

Subscribe To This Blog’s Feed

Free Consultation

Take The First Step In Resolving Your Issue. Send Us An Email.

Email Us For A Response

San Francisco
Bay Area Office

222 Rush Landing Road Novato, CA 94945

Novato Office
222 Rush Landing Road
Novato, CA 94945
Toll Free: 800-598-0314
Phone: 415-898-1555
Fax: 415-898-1247

Map & Directions

Southern California
Office

12 28th Street Venice, California 90291

Los Angeles Office
12 28th Street
Venice, California 90291
Toll Free: 800-598-0314
Phone: 415-898-1555
Fax: 415-898-1247

Map & Directions
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

© 2021 Brayton Purcell LLP. All Rights Reserved.

Disclaimer | Site Map | Privacy Policy | Business Development Solutions by FindLaw, part of Thomson Reuters

Review Us